Citation Tools
PDFRegular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
512 Time-of-day of pembrolizumab infusion and clinical outcomes of patients with NSCLC: too soon to promote morning infusions
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 512 Time-of-day of pembrolizumab infusion and clinical outcomes of patients with NSCLC: too soon to promote morning infusions